Northrop Grumman (NYSE: NOC) director sells 95 shares under plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Northrop Grumman director Mark A. Welsh III sold 95 shares of common stock in pre-planned transactions. On May 4, 2026, he executed 11 open-market sales at prices between $566.60 and $577.05 per share under a Rule 10b5-1 trading plan adopted on August 23, 2025. After these sales, he directly owned 4,121 Northrop Grumman shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 95 shares ($54,310)
Net Sell
11 txns
Insider
WELSH MARK A III
Role
null
Sold
95 shs ($54K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1 | $566.60 | $566.60 |
| Sale | Common Stock | 5 | $568.75 | $3K |
| Sale | Common Stock | 9 | $569.49 | $5K |
| Sale | Common Stock | 43 | $570.47 | $25K |
| Sale | Common Stock | 3 | $571.74 | $2K |
| Sale | Common Stock | 6 | $572.72 | $3K |
| Sale | Common Stock | 14 | $573.51 | $8K |
| Sale | Common Stock | 2 | $574.51 | $1K |
| Sale | Common Stock | 4 | $575.59 | $2K |
| Sale | Common Stock | 7 | $576.38 | $4K |
| Sale | Common Stock | 1 | $577.05 | $577.05 |
Holdings After Transaction:
Common Stock — 4,215 shares (Direct, null)
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 23, 2025. Represents the weighted average sale price of $568.75 rounded to the nearest hundredth. The highest price at which the shares were sold was $568.92 and the lowest price at which the shares were sold was $568.49. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $569.49 rounded to the nearest hundredth. The highest price at which the shares were sold was $569.97 and the lowest price at which the shares were sold was $569.01. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $570.47 rounded to the nearest hundredth. The highest price at which the shares were sold was $570.84 and the lowest price at which the shares were sold was $570.25. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $571.74 rounded to the nearest hundredth. The highest price at which the shares were sold was $571.98 and the lowest price at which the shares were sold was $571.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $572.72 rounded to the nearest hundredth. The highest price at which the shares were sold was $572.98 and the lowest price at which the shares were sold was $572.51. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $573.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $573.80 and the lowest price at which the shares were sold was $573.14. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $574.51 rounded to the nearest hundredth. The highest price at which the shares were sold was $574.66 and the lowest price at which the shares were sold was $574.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $575.59 rounded to the nearest hundredth. The highest price at which the shares were sold was $575.99 and the lowest price at which the shares were sold was $575.38. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4. Represents the weighted average sale price of $576.38 rounded to the nearest hundredth. The highest price at which the shares were sold was $576.87 and the lowest price at which the shares were sold was $576.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote in this Form 4.
Key Figures
Shares sold: 95 shares
Sale price range: $566.60–$577.05 per share
Post-transaction holdings: 4,121 shares
+2 more
5 metrics
Shares sold
95 shares
Total common stock sold on May 4, 2026 across 11 trades
Sale price range
$566.60–$577.05 per share
Lowest and highest reported transaction prices on May 4, 2026
Post-transaction holdings
4,121 shares
Direct Northrop Grumman common stock owned after reported sales
Number of sale transactions
11 transactions
Open-market sales of common stock reported in this Form 4
Trading plan adoption date
August 23, 2025
Adoption date of Rule 10b5-1 trading plan used for these sales
Key Terms
Rule 10b5-1 trading plan, weighted average sale price, open-market sale
3 terms
Rule 10b5-1 trading plan regulatory
"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"Represents the weighted average sale price of $568.75 rounded to the nearest hundredth"
open-market sale financial
"transaction_action": "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did Northrop Grumman (NOC) director Mark A. Welsh III report on this Form 4?
He reported selling 95 shares of Northrop Grumman common stock. The filing shows 11 open-market sale transactions on May 4, 2026, executed under a Rule 10b5-1 trading plan, with prices ranging from about $566.60 to $577.05 per share.
Was the Northrop Grumman (NOC) insider sale made under a Rule 10b5-1 plan?
Yes. The filing states the sales were made under a Rule 10b5-1 trading plan. A footnote explains that Mark A. Welsh III adopted this pre-arranged trading plan on August 23, 2025, indicating the timing of the sales was set in advance.
How many separate transactions did the Northrop Grumman (NOC) director execute in this Form 4?
The Form 4 reports 11 separate open-market sale transactions. All involved Northrop Grumman common stock on May 4, 2026, collectively totaling 95 shares sold and leaving Mark A. Welsh III with 4,121 shares held directly.
Does this Northrop Grumman (NOC) Form 4 show any option exercises or derivative transactions?
No, this Form 4 only reports non-derivative common stock sales. The derivativeSummary section is empty and the transactionSummary indicates zero exercises or derivative transactions, focusing solely on open-market sales of existing common shares.